Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Tax Liability (2016 - 2023)

Amphastar Pharmaceuticals has reported Non-Current Deferred Tax Liability over the past 11 years, most recently at $201000.0 for Q3 2023.

  • Quarterly results put Non-Current Deferred Tax Liability at $201000.0 for Q3 2023, down 16.94% from a year ago — trailing twelve months through Sep 2023 was $201000.0 (down 16.94% YoY), and the annual figure for FY2022 was $144000.0, down 73.03%.
  • Non-Current Deferred Tax Liability for Q3 2023 was $201000.0 at Amphastar Pharmaceuticals, roughly flat from $201000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for AMPH hit a ceiling of $2.9 million in Q3 2021 and a floor of $144000.0 in Q4 2022.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $748000.0 (2020), compared with a mean of $724222.2.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: skyrocketed 252.49% in 2021 and later crashed 91.66% in 2022.
  • Amphastar Pharmaceuticals' Non-Current Deferred Tax Liability stood at $867000.0 in 2019, then fell by 14.53% to $741000.0 in 2020, then dropped by 27.94% to $534000.0 in 2021, then plummeted by 73.03% to $144000.0 in 2022, then surged by 39.58% to $201000.0 in 2023.
  • The last three reported values for Non-Current Deferred Tax Liability were $201000.0 (Q3 2023), $201000.0 (Q2 2023), and $178000.0 (Q1 2023) per Business Quant data.